2024 Conference Agenda
Philadelphia, PA, 5 - 6 September 2024
Schedule
Create your personal agenda –check the favourite icon
Sep 58:40
Conference pass
Opening remarks from Terrapinn
Keynotes
Opening Remarks from Terrapinn
Sep 58:45
Conference pass
Chairperson's opening remarks
Keynotes
Recored remarks from Congressman Mike Levin
Sep 59:00
Conference pass
Keynote opening plenary: Never surrender: Mobilizing the global fight against antibiotic resistance
Keynotes
Sponsored by Recce Pharmaceuticals
Moderator: Erika Edwards, Health and Medical Reporter and Writer, NBC News
Alan W Dunton MD, Non-Executive Director, Recce Pharmaceuticals
Wes Kim, Director of Global Public Health Programs, American Society for Microbiology
Sep 59:20
Conference pass
Keynote Plenary: To be announced
Keynotes
Reserved for WHO
Sep 59:40
Conference pass
Keynote panel: Strengthening global health architecture to readily respond to the next health emergency
Keynotes
Other speakers to be announced
Moderator: Carolyn Reynolds, Co-Founder, Pandemic Action Network
David Boucher, Director, Infectious Disease Preparedness & Response, Biomedical Advanced Research And Development Authority
Wolfgang Philipp, Principal Adviser, Chief Science Officer, European Commission Health Emergency Preparedness & Response (HERA)
Sep 510:15
Conference pass
Keynote panel: Challenges and opportunities for access and stewardship in low income countries
Keynotes
Sponsored by GSK
Moderator: Oliver Barnes, US Pharmaceutical & Biotech Correspondent, Financial Times
Aruni Mulgirigama, Head of Infectious Diseases, General Medicines, Gsk
Sep 510:50
Conference pass
Morning Networking Break & Expo Hall Opens
Break
Morning Networking Break & Expo Hall Opens
Sep 511:15
Conference pass
Chair Person
Antibiotic Development
Bradley Burnam, Founder/Chief Executive Officer, Patient Advocate & Founder
Sep 511:15
Conference pass
Chair Person
AMR Diagnostics
Cepheid representative to be announced
Sep 511:15
Conference pass
Sep 511:15
Conference pass
Sep 511:15
Conference pass
Chair Person
Impact, Policy, & Awareness
Sep 511:15
Conference pass
Chair Person
One Health
Francesca Chiara, Director of Antimicrobial Resistance Stewardship, Center for Infectious Disease Research & Policy (CIDRAP)
Sep 511:15
Conference pass
Chair Person
Vaccines (DPC)
Harry Kleanthous, Executive Vice President, Vaccines R&D Strategy & External Innovation, SK Bioscience
Sep 511:15
Conference pass
Chair Person
New Technology (DPC)
Rick Bright, Founder, Bright Global Health
Sep 511:15
Conference pass
Chair Person
Global Collaboration & Partnership (DPC)
To be announced
Sep 511:20
Conference pass
Panel: Building the framework: Sustainable lab strengthening in LMICs
Antibiotic Stewardship
Moderator: Wes Kim, Director of Global Public Health Programs, American Society for Microbiology
Patrick Mateta, Board Chairman, African Society for Laboratory Medicine
Sep 511:20
Conference pass
Presentation: DISEASE X- The 100 days mission to end pandemics
Vaccines (DPC)
Kate Kelland, Chief Scientific Writer, Coalition for Epidemic Preparedness Innovations
Sep 511:20
Conference pass
Presentation: How can current reimbursement models be leveraged while waiting for ‘pull’ incentives?
Impact, Policy, & Awareness
Sponsored by Debiopharm
Jennifer Quinn, Head of Global Value and Access, Debiopharm International
Sep 511:20
Conference pass
Presentation: Impact of informational environment on intersectional communication for AMR & one health
One Health
Catherine Bertrand Ferrandis, Founder, OLYLO
Sep 511:20
Conference pass
Presentation: Novel DNA pol IIIC inhibitors for gram-positive bacterial infections: Lead product candidate ibezapolstat advancing to phase 3 trials
Innovation Showcase
Robert DeLuccia, Executive Chairman, Acurx Pharmaceuticals
Sep 511:20
Conference pass
Presentation: Project NextGen: Enhancing preparedness with next generation medical countermeasures
Global Collaboration & Partnership (DPC)
Robert Johnson, Director, Medical Countermeasures Programs, HHS/BARDA
Sep 511:20
Conference pass
Presentation: Pull incentives for AMR diagnostics
AMR Diagnostics
To be announced
Sep 511:20
Conference pass
Presentation: The promise of Recce anti-Infectives: Tackling AMR with cutting-edge treatments
Antibiotic Development
Sponsored by Recce Pharmaceuticals
Sep 511:20
Conference pass
Presentation: Upscaling innovation: Bringing visibility into vaccines supply chains within LMICs
New Technology (DPC)
Souleymane Sawadogo, Chief Global Heath Officer, Parsyl
Sep 511:40
Conference pass
Panel: Breaking the cycle: Tackling antibiotic overuse with smart data, enhanced stewardship, and diagnostic precision in outpatient care
AMR Diagnostics
Sponsored by Biomerieux
Sep 511:40
Conference pass
Panel: Navigating the future: Strategies and challenges in AMR policy development
Impact, Policy, & Awareness
Moderator: Taylor Sexton, Executive Director, Medical Countermeasures Coaltion
Paul Plummer, Executive Director, National Institute of Antimicrobial Resistance Research and Education (NIAMRRE)
Jonathan Daniels, US Policy Director, AMR Action Fund
David McKinney, Co-founder & Director, ARMOR - Alliance for Reducing Microbial Resistance
Sep 511:40
Conference pass
Presentation: Breaking barriers in antivirals : Xafty's singular solution for multiple respiratory viral infections
New Technology (DPC)
Heung Jeong Woo, Executive Vice President, Hyundai Bioscience
Sep 511:40
Conference pass
Presentation: Drawing public health insights from wastewater surveillance for AMR
One Health
Speaker to be announced
Sep 511:40
Conference pass
Presentation: Telementoring, equity and advocacy: Collaboration for health through antimicrobial stewardship
Antibiotic Stewardship
Amy Groom, Director of Immunization Initiatives, University of New Mexico Health Sciences Center, ECHO Institute
Sep 511:40
Conference pass
Presentation: To be announced
Antibiotic Development
To be announced
Sep 511:40
Conference pass
Presentation: To be announced
Innovation Showcase
Sponsored by CosmoID
Sep 511:40
Conference pass
Presentation: To be announced
Vaccines (DPC)
To be announced
Sep 511:40
Conference pass
Presentation: To be announced
Global Collaboration & Partnership (DPC)
To be annoucned
Sep 512:00
Conference pass
Panel: A one health approach: Wastewater surveillance for AMR
One Health
Sponsored by Resistomap
Moderator: Francesca Chiara, Director of Antimicrobial Resistance Stewardship, Center for Infectious Disease Research & Policy (CIDRAP)
Angela Coulliette-Salmond, Lead – Healthcare Wastewater Team, CDC
Claudio Ternieden, Executive Director, Water & Wastewater Equipment Manufacturers Association (WWEMA)
Nichole Brinkman, Biologist, US Environmental Protection Agency
Sep 512:00
Conference pass
Panel: Modernizing incentive structures: A roadmap to strengthen antimicrobial development
Antibiotic Development
Other speakers to be announced
Sep 512:00
Conference pass
Panel: Navigating the landscape - Strategies for early-stage developmental funding
Innovation Showcase
Sponsored by LifeArc
Moderator: Peter Seiler, Management Team, Support of Ventures, INCATE
Alex Moreland, Cofounder & CEO, Xiretsa
Mark Engel, CEO, Precisio Biotix
Sep 512:00
Conference pass
Panel: The role of AI for pandemic preparedness
New Technology (DPC)
Moderator: Rick Bright, Founder, Bright Global Health
Claire Wagner, Head of Corporate Strategy & Market Access, Bill and Melinda Gates Medical Research Institute
Charles Holmes, Director of the Georgetown Center for Innovation in Global Health, Georgetown University
Sep 512:00
Conference pass
Panel: To be announced
Global Collaboration & Partnership (DPC)
Reserved for Miami Public Health Policy Lab
Sep 512:00
Conference pass
Presentation: Incorporating social dynamics in antimicrobial stewardship implementation
Antibiotic Stewardship
Sep 512:00
Conference pass
Presentation: Preventing zoonotic spillover: The role of novel next-generation animal vaccines
Vaccines (DPC)
Sep 512:20
Conference pass
Fireside Chat: Building systems for effective vaccination-Access, communication, & policy
Vaccines (DPC)
To be announced
Sep 512:20
Conference pass
Fireside Chat: Impact, policy & awareness: Redefining value for novel outpatient antibiotics
Impact, Policy, & Awareness
Sponsored by GSK
Matthew Helgeson, Global Medical Director, GSK
John Billington, Head of Corporate & Commercial Policy, Gsk
Sep 512:20
Conference pass
Presentation: FebriDx; A rapid point-of-care test tool to aid clinicians in the reduction of antibiotic misuse in acute respiratory infections
AMR Diagnostics
Sponsored by Lumos Diagnostics
Nathan I. Shapiro, MD, MPH, Vice Chairman of Emergency Medicine Research , BIDMC & Professor of Emergency Medicine, Harvard Medical School, Lumos Diagnostics
Sep 512:50
Conference pass
Keynote panel : Building a common agenda for AMR: Finding the overlap between LMICs and high- middle income countries
Keynotes
Sponsored by AMR Action Fund
Sponsored by Sandoz
Moderator: Dana McLaughlin, Special Assistant to the Deputy Director and Chief of Staff, The White House
Henry Skinner, Chief Executive Officer, AMR Action Fund
Mirfin Mpundu, Director, React Africa
Boumediene Soufi, Global Head AMR, Sandoz
Annick Lenglet, Acting Science Director, International Centre for AMR solutions (ICARS)
Sep 513:30
Conference pass
Roundtable 10: To be announced
Roundtable
Reserved for Shionogi
Sep 513:30
Conference pass
Roundtable 2: Successful implementation of community health programs : A look Into Cardiovascular Health Initiative (CHI)
Roundtable
Sep 513:30
Conference pass
Roundtable 3: Next generation scientists for R&D of antimicrobials
Roundtable
Sep 513:30
Conference pass
Roundtable 4: One health and pathogen emergence: Understanding the movement between environment, animals, & humans
Roundtable
Vanessa Varaljay, Strategic Alliance Officer - Infectious Diseases Institute, The ohio state university
Sep 513:30
Conference pass
Roundtable 5: Applications of Global One Health Multifactorial AMR analyses to guide our understanding of its evolution and identify potential interventions
Roundtable
To be announced
Troy Skwor, Associate Professor, University of Wisconsin - Milwaukee
Sep 513:30
Conference pass
Roundtable 6: What data is needed to fit current payer evidence requirements and how can we generate it
Roundtable
Sponsored by Debiopharm
Jennifer Quinn, Head of Global Value and Access, Debiopharm International
Sep 513:30
Conference pass
Roundtable 7: To be announced
Roundtable
Sponsored by Cepheid
Sep 513:30
Conference pass
Roundtable 8: To be announced
Roundtable
Sponsored by Takara Bio
Sep 513:30
Conference pass
Roundtable 9: A broad spectrum antiviral: Xafty for future pandemic preparedness
Roundtable
Dr. C. Jo White, Medical Advisor, Hyundai Bioscience
Dr. Geun-woo Jin, Director of Research & Development, Hyundai Bioscience
Sep 514:10
Conference pass
Chair Person
Antibiotic Development
Bradley Burnam, Founder/Chief Executive Officer, Patient Advocate & Founder
Sep 514:10
Conference pass
Chair Person
AMR Diagnostics
Reserved for Cepheid
Sep 514:10
Conference pass
Sep 514:10
Conference pass
Chair Person
Innovation Showcase
To be announced
Sep 514:10
Conference pass
Chair Person
Impact, Policy, & Awareness
Sep 514:10
Conference pass
Chair Person
One Health
Francesca Chiara, Director of Antimicrobial Resistance Stewardship, Center for Infectious Disease Research & Policy (CIDRAP)
Sep 514:10
Conference pass
Chair Person
Vaccines (DPC)
Harry Kleanthous, Executive Vice President, Vaccines R&D Strategy & External Innovation, SK Bioscience
Sep 514:10
Conference pass
Chair Person
New Technology (DPC)
Rick Bright, Founder, Bright Global Health
Sep 514:10
Conference pass
Chair Person
Global Collaboration & Partnership (DPC)
To be announced
Sep 514:10
Conference pass
Short break before track sessions resume
Break
Short break before track sessions resume
Sep 514:15
Conference pass
Panel: AMR awareness: The next important step in our battle
Impact, Policy, & Awareness
Sponsored by Recce Pharmaceuticals
Sep 514:15
Conference pass
Panel: Delivery innovations for optimizing disease control and mitigating AMR
New Technology (DPC)
Moderator: Prashant Yadav, Affiliate Professor of Technology & Operations Management and Faculty Director, Africa Initiative, INSEAD
Brittany Hume Charm, Head of Growth, Global Health, Pendulum Systems
Dino Rech, Chief Executive Officer, Audere
Sep 514:15
Conference pass
Presentation: Advancing microbiome therapeutics as a novel technology in the arsenal against AMR
Innovation Showcase
Sponsored by Seres Therapeutics
Matthew Henn, Executive Vice President & Chief Scientific Officer, Seres Therapeutics Inc
Sep 514:15
Conference pass
Presentation: AI for antibiotic development
Antibiotic Development
César De La Fuente, Presidential Assistant Professor, University of Pennsylvania
Sep 514:15
Conference pass
Presentation: Evaluating vaccine efficacy against emerging pathogens: Standardized assay development
Vaccines (DPC)
Ali Azizi, Project Lead, CEPI
Sep 514:15
Conference pass
Presentation: International Instruments and tools to address AMR in the One Health scenario
One Health
Sep 514:15
Conference pass
Presentation: To be announced
AMR Diagnostics
To be announced
Sep 514:15
Conference pass
Presentation: To be announced
Global Collaboration & Partnership (DPC)
To be announced
Sep 514:15
Conference pass
Presentation: To be announced
Antibiotic Stewardship
To be announced
Sep 514:30
Conference pass
Roundtable 1: Certification Opportunities in Infection Prevention and Control: A Roundtable Discussion with the Certification Board of Infection Control & Epidemiology
Roundtable
Jessica Dangles, Executive Director - CBIC, Association for Professionals in Infection Control and Epidemiology
Sep 514:35
Conference pass
Presentation: Betting on the right therapeutic phage using high-performance bioinformatic
Innovation Showcase
Sponsored by Rime Bioinformatics
Antoine Culot, President, Rime Bioinformatics
Sep 514:35
Conference pass
Presentation: Precision microbiome engineering as an alternative to antibiotics to prevent bacterial infections in agriculture
One Health
Sep 514:35
Conference pass
Presentation: Pulling together – an industry perspective on how the NHS England subscription model aims to address the challenges for antimicrobial drug development
Antibiotic Development
Sponsored by Pfizer
Sep 514:35
Conference pass
Presentation: To be announced
AMR Diagnostics
To be announced
Sep 514:35
Conference pass
Presentation: To be announced
Global Collaboration & Partnership (DPC)
To be announced
Sep 514:35
Conference pass
Presentation: To be announced
Vaccines (DPC)
To be announced
Sep 514:55
Conference pass
Fireside Chat: Shaping UNGA Priorities: Global Citizens' Juries on AMR - Engaging the Public in Malawi, Thailand, and the US
Impact, Policy, & Awareness
Kyle Bozentko, Executive Director, Center for New Democratic Processes
Sep 514:55
Conference pass
Panel: Effective public private partnerships for pandemic response
Global Collaboration & Partnership (DPC)
Moderator: Hassanatu Blake, Director, Global Health Undergraduate Program, Associate Clinical Professor, University of Maryland School of Public Health
Niesha Foster, Vice President, Global Health & Social Impact, Pfizer
Paul Leon, Head of Government & NGO Strategy, AstraZeneca Pharmaceuticals
Sep 514:55
Conference pass
Panel: Cross-sector engagement: One health AMR success stories
One Health
Moderator: Kris Johansen, Associate Director of External Relations, National Institute of Antimicrobial Resistance Research and Education (NIAMMRE)
Jolieke van Oosterwijk, Chief Scientific Officer, US Biologic
Steven Harris, Chair -Department of Plant Pathology, Entomology and Microbiology, Iowa State University
Sep 514:55
Conference pass
Panel: Patient-centric approaches in the AMR drug pipeline
Antibiotic Development
Moderator: Debbie Goff, Infectious Diseases Specialist, College Of Pharmacy, Ohio State University Medical Center
Dee Grant, Patient Support Lead, Antibiotic Research UK
Ella Balasa, Patient Advocate, Patient Advocate
Bradley Burnam, Founder/Chief Executive Officer, Patient Advocate & Founder
Sep 514:55
Conference pass
Panel: The role of machine learning & AI for vaccine delivery
Vaccines (DPC)
Panelists to be announced
Lynda Stuart, Executive Director, Institute for Protein Design, University of Washington
Sep 514:55
Conference pass
Panel: The role of the IP, nurse and nurse practitioner: Driving antimicrobial stewardship at the bedside
Antibiotic Stewardship
Moderator: Kim Abbass, Clinical Coordinator Antimicrobial Stewardship and Pharmacy Practice, Eastern Zone,, Nova Scotia Health
Fatima Brakta, Clinical Pharmacy Manager, Easter Jefferson General Hospital
Mary Lou Manning, Director, Center for Infection Prevention and Antibiotic Stewardship, Thomas Jefferson University
Sep 514:55
Conference pass
Panel:The role of ID surveillance to reduce AMR
AMR Diagnostics
Sponsored by Cepheid
Anthony Darcovich, Patient advocate, WHO Patient Survivor’s Taskforce
Sep 514:55
Conference pass
Presentation: The impact of biofilms on AMR and challenges faced in antimicrobial efficacy testing
Innovation Showcase
Sponsored byTentamus Group
Tracy Rivett, Business Development Manager/ Biofilm specialist, Tentamus Pharma and Med
Sep 514:55
Conference pass
Presentation: To be announced
New Technology (DPC)
To be announced
Sep 515:15
Conference pass
Presentation: Evaluating Vaccine Efficacy Against Emerging Pathogens: Standardized Assay Development
New Technology (DPC)
Ami Patel, Assistant Professor, The Wistar Institute
Sep 515:15
Conference pass
Presentation: To be announced
Impact, Policy, & Awareness
Sep 515:35
Conference pass
Short break before keynotes
Break
Short break before keynotes
Sep 515:45
Conference pass
Afternoon Chairperson Opening Remarks
Keynotes
Melissa Mitchell, Secretariat Lead, AMR Industry Alliance
Sep 515:50
Conference pass
Keynote Plenary: Implementing the 100 day mission into action: Where are we now?
Keynotes
Other panelists to be announced
Moderator: Oliver Barnes, US Pharmaceutical & Biotech Correspondent, Financial Times
Sep 516:30
Conference pass
Keynote panel: From awareness to action: Identifying tailored solutions for AMR
Keynotes
Reserved for Menarini
Moderator: Corinne Purtill, Science & Medicine Reporter, L.A. Times
Diane Shader Smith, Independent Public Relations and Communications Professional, Patient Advocate
Melissa Mitchell, Secretariat Lead, AMR Industry Alliance
Sep 517:10
Conference pass
Keynote panel: Global champions for AMR: Shaping narratives and influencing policy with the first taskforce of AMR survivors
Keynotes
Moderator: Michelle Cortez, Global Health Care Reporter, Senior Editor, Bloomberg News
Ella Balasa, Patient Advocate, Patient Advocate
Nour Shamas, Antimicrobial Stewardship & Infectious Disease Clinical Pharmacist, AMR Patient Survivor and Advocate
Anthony Darcovich, Patient advocate, WHO Patient Survivor’s Taskforce
Rob Purdie, Founder and Managing Director, Mycology Advocacy, research and Education (MyCARE)
Create your personal agenda –check the favourite icon
Sep 68:00
Conference pass
Registration opens
Keynotes
Registration opens
Sep 68:40
Conference pass
Keynote: Chairperson’s opening remarks
Keynotes
Jomana Musmar, Executive Director, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, DHHS
Sep 68:45
Conference pass
Keynote Address: AMR: Tackling a silent pandemic with a one-health approach
Keynotes
Sponsored by bioMerieux
Brian Raux, Medical Advisor, bioMerieux
Sep 69:05
Conference pass
Keynote panel: Putting AMR on the global agenda: Setting targets, accelerating action, and ensuring accountability
Keynotes
Sponsored by Pfizer
Jeremy Knox, Head of Policy, Infectious Diseases, Wellcome Trust
Sep 69:40
Conference pass
Keynote Plenary: Why the world needs its own immune system
Keynotes
Sponsored by Cocentric by Ginkgo
Moderator: Kate Kelland, Chief Scientific Writer, Coalition for Epidemic Preparedness Innovations
Mitchell Wolfe, Vice President of Global Engagement & Governance, Ginkgo Bioworks, Inc.
Thomas Tsai, Chief Medical Advisor, Ginkgo Bioworks, Inc.
Sep 610:20
Conference pass
Expo and networking break
Break
Expo and networking break
Sep 610:55
Conference pass
Chair Person
Antibiotic Commercalization
To be announced
Sep 610:55
Conference pass
Chair Person
AMR Diagnostics
Reserevd for Cepheid
Sep 610:55
Conference pass
Chair Person
AMR Vaccines
To be announced
Sep 610:55
Conference pass
Chair Person
Innovation Showcase
To be announced
Sep 610:55
Conference pass
Chair Person
Impact, Policy, & Awareness
Marjorie Korn, Deputy Communications Director, AMR Action Fund
Sep 610:55
Conference pass
Chair Person
Genomics & Surveillance
To be announced
Sep 610:55
Conference pass
Chair Person
Infection Prevention
Sep 610:55
Conference pass
Chair Person
Diagnostics & Surveillance (DPC)
To be announced
Sep 610:55
Conference pass
Chair Person
Funding & Preparedness (DPC)
Sep 611:00
Conference pass
Fireside chat: A new grand bargain to improve the antimicrobial market for human health
Antibiotic Commercalization
Javier Guzman, Director, Global Health Policy, Center for Global Development
Sep 611:00
Conference pass
Fireside chat: Infectious disease detection and surveillance project
Diagnostics & Surveillance (DPC)
Lungi Okoko, Senior Program Officer, Global Health, The Bill & Melinda Gates Foundation
Sep 611:00
Conference pass
Investors panel: Seeking returns from investing in anti-infectives
Innovation Showcase
Moderator: Aleks Engel, Director, REPAIR Impact Fund, Novo Holdings
Mark Bamforth, General Partner, Kineticos AMR Accelerator Fund I, Kineticos Life Sciences
Fei Shen, Investment Director, Boehringer Ingelheim Venture Fund
Martin Heidecker, Chief Investment Officer, AMR Action Fund
Bita Sehat, Senior Investment Director, Trill Impact Ventures
Sep 611:00
Conference pass
Panel: Building a Pandemic-Resilient Society: Making the Investment Case for Pandemic Preparedness
Funding & Preparedness (DPC)
Moderator: Justin Yang, Co-Founder, Kaibab Health & DMV Bio
A'in Nur, Project Executive, Asia-Europe Foundation
Kevan Oconnor, Venture Investor, Cystic Fibrosis Foundation
Giulia Balconi, Investor, Adjuvant Capital
Sep 611:00
Conference pass
Panel: Everything, everywhere, all at once. Why the common thread in resistant, infectious diseases may be biofilms
Infection Prevention
Sponsored by N8 Medical
Moderator: Ted Buckley, Vice President, Government Affairs, Shionogi Inc.
Steve St. Onge, SVP -Corporate Development, Clarametyx Biosciences
Diane Shader Smith, Independent Public Relations and Communications Professional, Patient Advocate
Maud Eijkenboom, Managing Director, Lixa
Carl Genberg, Chief Scientific and Development Officer, N8 Medical
Sep 611:00
Conference pass
Panel: To be announced
AMR Vaccines
Reserved for CARB-X
Sep 611:00
Conference pass
Presentation: Breaking down barriers: Health equity strategies for underrepresented communities
Impact, Policy, & Awareness
Jovonni Spinner, Chief Executive Officer & Founder, Beacon Public Health
Sep 611:00
Conference pass
Presentation: Bridging the gap: Transitioning rapid detection methods for food safety use
AMR Diagnostics
Cheryl Armstrong, Research Microbiologist, USDA
Sep 611:00
Conference pass
Presentation: Tackling antimicrobial resistance in healthcare: The significance of robust health and economic data
Genomics & Surveillance
Sep 611:20
Conference pass
Panel: Women's health: AMR today & more importantly, tomorrow
Impact, Policy, & Awareness
Moderator: Beth Battaglino, Chief Executive Officer, HealthyWomen
Carolyn Reynolds, Co-Founder, Pandemic Action Network
Uzma Syed, Board Member, Sepsis Alliance
Sep 611:20
Conference pass
Presentation: A future call on diagnostics: Addressing the global antimicrobial & diagnostic pipeline through the UK PACE initiative
AMR Diagnostics
Sep 611:20
Conference pass
Presentation: To be announced
Antibiotic Commercalization
To be announced
Sep 611:20
Conference pass
Presentation: To be announced
Genomics & Surveillance
Sponsored by Takara Bio
Rohit Kadam, Product Manager - qPCR applications, Takara Bio USA
Sep 611:20
Conference pass
Presentation: To be announced
Diagnostics & Surveillance (DPC)
To be announced
Sep 611:40
Conference pass
Panel: Diagnostics partnerships to combat AMR in LMICs
AMR Diagnostics
Elijah Kahn-Woods, Innovation Advisor, Center for Innovation and Impact, USAID
Sep 611:40
Conference pass
Panel: Leveraging partnerships for antimicrobial developments
Antibiotic Commercalization
Moderator: John Alter, Head of External Affairs, AMR Action Fund
Yann Ferrisse, Director, Business Development & Partner Engagement, GARDP
Sep 611:40
Conference pass
Panel: Pandemic risks, management, & mitigation: Conversations with local health officials
Diagnostics & Surveillance (DPC)
Moderator: Meghan Pennini, Chief Therapeutics Officer, HCORE, HHS
Syra Madad, Senior Director, System-wide Special Pathogens Program, NYC Health + Hospitals
Meredith Allen, Vice President, Health Security, Association of State and Territorial Health Officials (ASTHO)
Sep 611:40
Conference pass
Panel: The economic burden of AMR
Genomics & Surveillance
IHME representative to be announced
Moderator: Jomana Musmar, Executive Director, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, DHHS
Jeremy Knox, Head of Policy, Infectious Diseases, Wellcome Trust
Anthony McDonnell, Senior Policy Analyst, Center for Global Development
Sep 611:40
Conference pass
Presentation: Future breakthrough therapy in the prevention of AMR infections - A synthetic, autonomous, AI-chosen microbiome based biotherapeutic. Human Biome's journey to make it real
Innovation Showcase
Sep 611:40
Conference pass
Presentation: Liposomal encapsulation of polysaccharides (LEPS) as an effective vaccine strategy to protect aged hosts against S. pneumoniae infection
AMR Vaccines
Manmeet Pal Singh Bhalla, Senior Research Scientist, University at Buffalo
Sep 611:40
Conference pass
Presentation: What’s next? Predicting and preparing for the next pandemic
Funding & Preparedness (DPC)
Sep 612:00
Conference pass
Fireside chat: Diversity in clinical trials
Impact, Policy, & Awareness
David Almeida, CEO & Founder, Brooklyn Clinical Research
Sep 612:00
Conference pass
Presentation: Engaging ecosystems: Driving political actions & commitments to strengthen pandemic response
Funding & Preparedness (DPC)
Claire Wingfield, Director, Partnerships & Advocacy, FIND
Sep 612:00
Conference pass
Presentation: Rifampin-resistant Tuberculosis- A pediatric cluster investigation
Infection Prevention
Margaret Gilman, Director, Infection Prevention and Control, Nemours Children's Hospital, Delaware
Sep 612:00
Conference pass
Presentation: To be announced
AMR Vaccines
To be announced
Sep 612:00
Conference pass
Presentation: To be announced
Innovation Showcase
To be announced
Sep 612:20
Conference pass
Networking break & film screening: HOLOBIOME
Break
What if you found out that, on a cellular level, you, your body at least, is more microbial than human. And what if it wasn’t just your body that is more microbial than it seems, but that almost everything, all life on earth, is made possible by microbes? The concept of the Holobiome captures this reality and also beckons us to reconsider our understanding of health and infectious disease, along with our relationship to the microbial world. This series currently features two innovative short films that explore this emergent, holobiome, understanding of life and health.
Film 1 Maddie's Transplant (20min) is a documentary featuring the harrowing tale of a young woman and her mother confronting what happens when the human immune system becomes compromised and the drugs stop working.
Film 2 Bradley's Burden (18min) is a sci-fi / documentary hybrid explores the future past of biotechnology and the need for innovation and more innovative thinking in our relationship with infectious diseases and the microbial world
Sep 613:00
Conference pass
Roundtable 1: To be annnounced
Roundtable
To be announced
Sep 613:00
Conference pass
Roundtable 10: To be announced
Roundtable
To be announced
Sep 613:00
Conference pass
Roundtable 2: AMR-related grant funding through the agency for Healthcare Research and Quality (AHRQ): Areas of interest and tips for success
Roundtable
Susan Henderson, Medical Officer, AHRQ/ CQUiPS
Sep 613:00
Conference pass
Roundtable 3: Overcoming misinformation and restoring trust in public health in rural Tennessee through cinema
Roundtable
Mark Chee, Assistant Professor of Biology, Hood College
Sep 613:00
Conference pass
Roundtable 4: Targets and accountability: How can progress be maintained in the global response to AMR beyond this year’s UN High-Level Meeting
Roundtable
Sep 613:00
Conference pass
Roundtable 5: Antibiotic stewardship in veterinary medicine: Progress and remaining challenges?
Roundtable
Laurel Redding, Assistant Professor of Epidemiology, University of Pennsylvania
Sep 613:00
Conference pass
Roundtable 6: Innovation for broadband anti-infectives targeting pandemic preparedness and the growing challenge of antimicrobial resistance
Roundtable
Karsten Ottenberg, Chairman, AATec Medical
Sep 613:00
Conference pass
Roundtable 7: To be announced
Roundtable
To be announced
Sep 613:00
Conference pass
Roundtable 8: To be announced
Roundtable
To be announced
Sep 613:00
Conference pass
Roundtable 9: To be announced
Roundtable
To be announced
Sep 613:40
Conference pass
Chair Person
Antibiotic Commercalization
To be announced
Sep 613:40
Conference pass
Chair Person
Antibiotic Stewardship
To be announced
Sep 613:40
Conference pass
Chair Person
AMR Vaccines
To be announced
Sep 613:40
Conference pass
Chair Person
Innovation Showcase
To be announced
Sep 613:40
Conference pass
Chair Person
Fungals
To be announced
Sep 613:40
Conference pass
Chair Person
Genomics & Surveillance
To be announced
Sep 613:40
Conference pass
Chair Person
Infection Prevention
Sep 613:40
Conference pass
Chair Person
Diagnostics & Surveillance (DPC)
To be announced
Sep 613:40
Conference pass
Chair Person
Funding & Preparedness (DPC)
Sep 613:40
Conference pass
Short Break Before Track Sessions Resume
Break
Short Break Before Track Sessions Resume
Sep 613:50
Conference pass
Panel: Economic & procurement tools to improve antibiotic access: SECURE and other initiatives
Antibiotic Commercalization
Other speakers to be announced
Moderator: Javier Guzman, Director, Global Health Policy, Center for Global Development
Brenda Waning, Chief, Global Drug Facility (GDF)
Benjamin Park, Senior Specialist, AMR/ IPC, The Global Fund
Sep 613:50
Conference pass
Presentation: Adapting for accessibility & affordability: Saliva as a sample type to overcome testing barriers for better outbreak control
Diagnostics & Surveillance (DPC)
Sep 613:50
Conference pass
Presentation: Candida auris: Turning challenges into successes at your healthcare facility
Fungals
Sep 613:50
Conference pass
Presentation: From bedside to clinic: Navigating the landscape of antimicrobial stewardship challenges
Antibiotic Stewardship
Kevin Nguyen, Infectious Diseases Pharmacist & Associate Director of Antimicrobial Stewardship, St Christophers Hospital for Children
Sep 613:50
Conference pass
Presentation: Harnessing the power of genomics to understand antimicrobial resistance emergence in the environment
Genomics & Surveillance
Thanh Nguyen, Professor, University of Illinois
Sep 613:50
Conference pass
Presentation: Impact of COVID on consumption of antimicrobials
Infection Prevention
Tauqeer Mustafa, Public Health Specialist, Fleming Fund
Sep 613:50
Conference pass
Presentation: NIAD's pandemic preparedness plan
Funding & Preparedness (DPC)
Jane Knisely, Pandemic Preparedness Strategy Coordinator, Division of Microbiology and Infectious Disease, NIAID, NIH
Sep 613:50
Conference pass
Presentation: To be announced
AMR Vaccines
Reserved for BacVax
Sep 613:50
Conference pass
Presentation: To be announced
Innovation Showcase
Speaker to be announced
Sep 614:10
Conference pass
Fireside chat: Institutional investors: Allies in the fight against AMR
Innovation Showcase
Emma Berntman, Senior Engagement Specialist AMR, FAIRR Initiative
Sep 614:10
Conference pass
Panel: Role of certification in reducing risk of infection and transmission of AMR
Infection Prevention
Moderator: Jessica Dangles, Executive Director - CBIC, Association for Professionals in Infection Control and Epidemiology
Sep 614:10
Conference pass
Presentation: Building trust & reimagining health for the 21st century
Funding & Preparedness (DPC)
To be announced
Sep 614:10
Conference pass
Presentation: Clinicians underutilize novel antibiotics in AMR infections: What will it take to move the dial?
Antibiotic Stewardship
Sameer Kadri, MD, ICU Physician and AMR Epidemiologist, NIH CLINICAL CENTER
Sep 614:10
Conference pass
Presentation: Developing first-in-class mAbs targeting novel, fungal cell wall proteins as safer and efficacious therapies for invasive fungal infections
Fungals
Soumya Palliyil, Head of Scottish Biologics Facility, University of Aberdeen
Sep 614:10
Conference pass
Presentation: Emerging antimicrobial resistance: The importance of vaccines and the role of investors
AMR Vaccines
Giulia Balconi, Investor, Adjuvant Capital
Sep 614:10
Conference pass
Presentation: The challenges and promise of using pan-pathogen diagnostics and metagenomics for surveillance and discovery
Diagnostics & Surveillance (DPC)
Sep 614:10
Conference pass
Presentation: To be announced
Genomics & Surveillance
To be announced
Sep 614:30
Conference pass
Panel: From new drug developments to new approaches: Tackling the emerging threat of anti-fungal resistance
Fungals
Moderator: Rob Purdie, Founder and Managing Director, Mycology Advocacy, research and Education (MyCARE)
Carol Munro, Professor, University of Aberdeen
Sep 614:30
Conference pass
Panel: Detecting and correcting misinformation online - What's next?
Funding & Preparedness (DPC)
Moderator: Erika Edwards, Health and Medical Reporter and Writer, NBC News
Katrine Wallace, Epidemiologist, University of Illlinois Chicago
Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics
Paul Offit, Physician, Childrens Hospital of Pennsylvania
Eric Burnett, Hospitalist, Columbia University Irving Medical Center
Sep 614:30
Conference pass
Panel: Strengthening antibiotic regulation: Antimicrobial Resistance in lower-middle-income countries and its global implications
Antibiotic Commercalization
Mirfin Mpundu, Director, React Africa
Amita Gupta, Director - Division of Infectious Diseases, Johns Hopkins University
Sep 614:30
Conference pass
Panel: To be announced
AMR Vaccines
To be announced
Sep 614:30
Conference pass
Panel: To be announced
Diagnostics & Surveillance (DPC)
To be announced
Sep 614:30
Conference pass
Presentation: Agency for Healthcare Research and Quality (AHRQ) AMR-related activities: Research to implementation
Antibiotic Stewardship
Susan Henderson, Medical Officer, AHRQ/ CQUiPS
Sep 614:30
Conference pass
Presentation: Cracking the code: MDRO surveillance secrets revealed
Genomics & Surveillance
Sean Brown, Associate Director of Infection Prevention & Control, NYC Health + Hospitals
Sep 614:30
Conference pass
Presentation: Next steps: Standardizing guidelines for phage susceptibility testing
Innovation Showcase
Sep 614:50
Conference pass
Presentation: Regulatory considerations in the development of bacteriophage for clinical use
Innovation Showcase
Sep 614:50
Conference pass
Presentation: To be announced
Infection Prevention
To be announced
last published: 26/Jul/24 12:56 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events